CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-16 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2021-06-16 | Zausner Meryl Director | Grant or award · Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2021-06-01 | Arkowitz David Chief Financial Officer | Grant or award · Stock Options (right to buy) | +270,000 | 270,000 | ||
| 2021-06-01 | Arkowitz David Chief Financial Officer | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2021-05-17 | Nutritional Health LTP Fund General Partner LLC 10% owner | Other disposition | −295,171 | 2,962,963 | ||
| 2021-02-04 | DesRosier Thomas Chief Legal Officer and EVP | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-02-04 | Chapman Marcus | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2021-02-04 | Chapman Marcus | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2021-02-04 | von Moltke Lisa | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2021-02-04 | Young Teresa L. | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-02-04 | Shaff Eric D. President, CEO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2021-02-04 | Henn Matthew R. | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2020-12-01 | Henn Matthew R. | Exercise or conversion | +26,000 | $0.71 | $18K | 38,000 |
| 2020-12-01 | Henn Matthew R. | Exercise or conversion | +26,250 | $9.89 | $260K | 64,250 |
| 2020-12-01 | Henn Matthew R. | Exercise or conversion | +27,562 | $6.01 | $166K | 91,812 |
| 2020-12-01 | Henn Matthew R. | Sale | −55,706 | $26.56 | $1.5M | 36,106 |
| 2020-12-01 | Henn Matthew R. | Sale | −26,265 | $27.56 | $724K | 9,841 |
| 2020-12-01 | Henn Matthew R. | Sale | −9,841 | $28.34 | $279K | 0 |
| 2020-12-01 | Henn Matthew R. | Exercise or conversion · Stock Option (Right to Buy) | −26,000 | 0 | ||
| 2020-12-01 | Henn Matthew R. | Exercise or conversion · Stock Option (Right to Buy) | −26,250 | 3,750 |
Page 22 of 23 · 458 trades